All News

Two lawsuits have been filed against Anthem Blue Cross for denying coverage to 2 women for the hepatitis C medication Harvoni.

An international study has estimated that in 2013, there were 14.9 million newly diagnosed cases of cancer and 8.2 million deaths around the world.

At Patient-Centered Diabetes Care held April 16-17 in Boston, Massachusetts, Patrick J. O'Connor, MD, MA, MPH, senior clinical investigator at HealthPartners Institute for Education and Research and clinical associate professor or family medicine and community health at the University of Minnesota School of Medicine, kicked off the meeting with a discussion communicating treatment information to patients.

Children and families can benefit so much from these camps. Yes, MCOs should pay and here is why.

Despite fast adoption of electronic health records (EHRs) over the past 5 years, many clinicians have voiced concerns about the unintended clinical consequences of EHR use, such as reduced time for patient-clinician interactions, burdensome data entry tasks for front-line clinicians, and interoperability troubles.

While the concept of informed consent it a good one, there is a fundamental problem with the informed consent and how it is practiced today, writes Harlan Krumholz, MD, SM, professor of cardiology, epidemiology, and public health.

A randomized clinical trial conducted across at 215 sites in 35 countries has established that earlier antiretroviral treatment benefits all HIV-infected individuals.

A new payment model through the Affordable Care Act seeks to decrease cardiovascular disease for tens of thousands of Medicare beneficiaries by assessing patient risks for heart attack and stroke and then helping them to reduce those risks.

Cancer patients under the age of 65 are much more likely to try alternative and complimentary medicine to ease their symptoms and the side effects of their cancer treatments.

Individuals who enrolled in health insurance on the Affordable Care Act's marketplaces had lower average drug spending and were less likely to use most medication classes than patients with employer-sponsored coverage, according to a study published in Health Affairs.

The suits are on behalf of providers and health insurance customers and involve some famous plaintiffs' attorneys.

It is with an incredibly heavy heart that we must announce the death of our good friend and AJMC associate editor, Seema Sonnad. Seema suffered a fatal cardiac arrhythmia while running an ultramarathon in Seattle.

A study published in the New England Journals of Medicine evaluated the ability of financial incentives in promoting smoking cessation.

The medical loss ratio recommendation sought by CMS mirrors requirements for qualified health plans under the ACA. Insurers say a blanket requirement will not align with successful measures at work in several states.

Two organizations representing patients have demanded a common system of price-fixing for new drugs in Europe.

Introduced with good intent, some of the provisions of the Orphan Drug Act may compel the FDA to rethink its strategy.

A review of the benefit design choices made by states that expanded Medicaid (as of the end of 2014), revealed that states are offering more generous coverage that what is required under federal law, according to researchers with The Commonwealth Fund.

Packaging by itself is an adherence technology and will revolutionize data collection on adherence, but the future will find this technology part of the greater plecosystem using a virtual health assistant as the "air traffic controller.

Steve Miller, MD, chief medical officer of Express Scripts, explained indication-specific pricing as an alternate pricing model for high cost specialty medications like oncology drugs.

Consumer protections and rules to promote the march to value-based care are highlights of the massive proposal.

On January 1, 2015, the Centers for Medicare & Medicaid Service (CMS) introduced 4 Healthcare Common Procedure Coding System modifiers, known collectively as the - X(EPSU) modifiers, as a subset of Current Procedural Terminology (CPT) modifier 59 (distinct procedural service).

Innovative care delivery programs intended to improve quality and reduce costs need sustainable business models in order to last beyond the end of grants or other methods of time-limited funding. RAND researchers take a look at methods Massachusetts health plans and accountable care organizations are using.

Taking the time to educate patients before their medical device implantation has positive implications for patients, healthcare providers, and medical device manufacturers, according to a new poll.

An account in The New York Times comes closest to identfying the drafting error that set in motion King v. Burwell, the case that could unravel a key feature of the Affordable Care Act. Meanwhile, experts predict that a ruling for the plaintiffs will create political fallout for more Republicans than Democrats.

Published in the Canadian Medical Association Journal, the study found that the scale can help predict readmission or death within 30 days after hospital discharge among geriatric patients.

The results of an ongoing study, presented at the annual meeting of the Heart Failure Association of the European Society of Cardiology in Seville, Spain, identified a 5-fold increased risk of death in heart failure patients who were depressed.

As more patients become insured under the Affordable Care Act, driving demand for primary care and urgent care services, there is an increased need for alternative service sites, according to an analysis from Alvarez & Marsal.

The Obama Administration says that Florida can receive $1 billion this year and $600 million next year to pay for uncompensated care in safety net hospitals. However, the administration made it clear that more funding awaits the state if Medicaid expansion reaches those up to 138% of the federal poverty line.

German health authorities are debating whether the price of Europe's first approved gene therapy is worth the $1 million price tag.

Consumers with chronic diseases face challenging trade-offs when choosing health coverage, especially when it comes to out-of-pocket drug costs.